[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339793-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339793-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","onc206-targeting-clpp-induces-mitochondrial-dysfunction-and-protective-autophagy-in-hepatocellular-carcinoma-cells-original-research","ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells - Original Research","","Hepatocellular carcinoma (HCC) remains highly lethal despite advances in systemic therapies, creating a need for novel targeted treatments. ONC206, a potent imipridone analog, suppresses HCC growth by inhibiting proliferation and triggering apoptosis. It also induces cytoprotective autophagy, and autophagy blockade further potentiates ONC206-mediated cell death. Mechanistically, ONC206 causes mitochondrial swelling, decreased mitochondrial membrane potential, accumulation of mitochondrial ROS, and consequent mitochondrial dysfunction through ClpP.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/onc206-targeting-clpp-induces-mitochondrial-dysfunction-and-protective-autophagy-in-hepatocellular-carcinoma-cells-original-research/339793/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/onc206-targeting-clpp-induces-mitochondrial-dysfunction-and-protective-autophagy-in-hepatocellular-carcinoma-cells-original-research/339793.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main anti-cancer effect of ONC206 in hepatocellular carcinoma cells?","Question",{"text":63,"@type":64},"ONC206 hinders HCC growth by suppressing cell proliferation and inducing apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does autophagy influence ONC206’s impact on HCC cells?",{"text":68,"@type":64},"ONC206 induces cytoprotective autophagy; blocking autophagy enhances the pro-apoptotic effect of ONC206.",{"name":70,"@type":61,"acceptedAnswer":71},"Through what mechanism does ONC206 cause mitochondrial dysfunction in HCC cells?",{"text":72,"@type":64},"ONC206 induces mitochondrial swelling, reduces mitochondrial membrane potential, and leads to accumulation of mitochondrial ROS, ultimately resulting in mitochondrial dysfunction mediated by ClpP.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339793,1790625129,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Neoplasia 55 (2024) 101015  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells |  |  | |\n| --- | --- | --- | --- |\n| Jiahao Cao a, b, 1 , Fei Cao a, 1 , Chuanzheng Wang a , Zhen Jiao a , Yuting You a , Xiaomin Wang a, * , Wenxiu Zhao a, *\u003Cbr>a Xiamen Key Laboratory of Translational Medical of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361004, PR China\u003Cbr>b Department of Thyroid Head and Neck Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314099, PR China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords: HCCONC206 ClpP\u003Cbr>mitochondrial dysfunction protective autophagy |  | Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for approximately 90 % of all cases. ONC201, a member of the imipridone drug family, has shown promising therapeutic potential and a good safety profile in both malignant pediatric central nervous system tumors (diffuse midline glioma [DMG]) and hematologic malignancies. ONC206 is a more potent analog of ONC201. However, the ONC206 potential and mechanism of action in HCC remain to be elucidated. We found that ONC206 hindered HCC growth by suppressing cell proliferation and inducing apoptosis. Moreover, ONC206 induced cytoprotective autophagy, and blocking autophagy enhanced the proapoptotic effect of ONC206. Additionally, ONC206 induced mitochondrial swelling, reduced the mitochondrial membrane potential (MMP), and led to the accumulation of mitochondrial ROS in HCC cells, ultimately resulting in mitochondrial dysfunction. The HCC patient samples exhibited notably elevated levels of caseinolytic protease proteolytic subunit (ClpP), which serves as a mediator of ONC206-induced mitochondrial dysfunction and the activation of protective autophagy. knockdown of ClpP reversed the cytotoxic effects of ONC206 on HCC cells. In summary, our results provide the first insight into the mechanism by which ONC206 exerts its anti-HCC effects and induces protective autophagy in HCC cells through ClpP. |  |\n\nIntroduction  \nPrimary liver cancer is a prevalent malignancy and is the fourth leading cause of cancer-related deaths worldwide [1]. Hepatocellular carcinoma (HCC) accounts for more than 90 % of primary liver cancers. Radical liver resection and liver transplantation have been the mainstays of treatment for HCC [2]. Unfortunately, HCC is characterized by high mortality and poor prognosis [3], with only 5 % to 15 % of patients eligible for surgical resection. Despite substantial advances in systemic therapies [4], that have improved the overall survival and quality of life of HCC patients, long-term outcomes in HCC patients still remain poor. Consequently, there is an urgent need for novel targeted therapies to treat advanced HCC.  \nImipridones, a class of anticancer compounds characterized by their three-heterocyclic core chemical structure, have exhibited remarkable inhibitory effects on cancer cells through the increased expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and death receptor 5 (DR5), activation of the integrated stress response (ISR), and inhibition of the mTOR and Akt/ERK pathways [5-7]. Recently, emerging data have indicated that mitochondrial caseinolytic protease proteolytic subunit (ClpP) is the actual target of imipridones [8-10] and that imipridones disrupt mitochondrial metabolism through excessive ClpP activation and induce an energy-deprived state in cancer cells [10-12]. ONC206, a member of the imipridone family of drugs, is currently undergoing clinical huma","cbCaildz3TMVhGtV","https://ap.wps.com/l/cbCaildz3TMVhGtV","pdf",15420811,15,"English","# Introduction\n## Rationale for targeted therapy in HCC\n## Imipridones and mitochondrial ClpP as targets\n# ONC206 mechanisms related to mitochondrial dysfunction and autophagy\n## Role of ClpP and mitochondrial effects","[{\"question\":\"What is the main anti-cancer effect of ONC206 in hepatocellular carcinoma cells?\",\"answer\":\"ONC206 hinders HCC growth by suppressing cell proliferation and inducing apoptosis.\"},{\"question\":\"How does autophagy influence ONC206’s impact on HCC cells?\",\"answer\":\"ONC206 induces cytoprotective autophagy; blocking autophagy enhances the pro-apoptotic effect of ONC206.\"},{\"question\":\"Through what mechanism does ONC206 cause mitochondrial dysfunction in HCC cells?\",\"answer\":\"ONC206 induces mitochondrial swelling, reduces mitochondrial membrane potential, and leads to accumulation of mitochondrial ROS, ultimately resulting in mitochondrial dysfunction mediated by ClpP.\"}]","ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells - Original Research | PDF",1790032248,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b774e2055bbcb8dd771e528b493349a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dc4f17e82c1ddb41f13f708eb3764f7.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4db1d45f00b2dfc304dcafe76b8abcf6.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ce9d281679c682fc53229546cd2259d.webp",980,1306]